Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate STAAR Surgical Company before investing.

In this article, we go over a few key elements for understanding STAAR Surgical Company’s stock price such as:

• STAAR Surgical Company’s current stock price and volume
• Why STAAR Surgical Company’s stock price changed recently
• Upgrades and downgrades for STAA from analysts
• STAA’s stock price momentum as measured by its relative strength

About STAAR Surgical Company (STAA)

Before we jump into STAAR Surgical Company’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Want to learn more about STAAR Surgical Company’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about STAAR Surgical Company.

STAAR Surgical Company’s Stock Price as of Market Close

As of May 12, 2025, 12:49 PM, CST, STAAR Surgical Company’s stock price was $20.430.

STAAR Surgical Company is up 5.2% from its previous closing price of $19.420.

During the last market session, STAAR Surgical Company’s stock traded between $20.130 and $21.150. Currently, there are approximately 49.34 million shares outstanding for STAAR Surgical Company.

STAAR Surgical Company’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

STAAR Surgical Company Stock Price History

STAAR Surgical Company’s (STAA) price is currently up 11.88% so far this month.

During the month of May, STAAR Surgical Company’s stock price has reached a high of $21.150 and a low of $17.940.

Over the last year, STAAR Surgical Company has hit prices as high as $49.860 and as low as $13.500. Year to date, STAAR Surgical Company’s stock is down 15.89%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused STAAR Surgical Company Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. However, as of May 09, 2025,, no analysts have changed their rating of STAAR Surgical Company’s stock over the last month.

Additionally, you'll want to evaluate STAAR Surgical Company’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on STAAR Surgical Company’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

STAAR Surgical Company’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about STAAR Surgical Company (STAA) by visiting AAII Stock Evaluator.

Relative Price Strength of STAAR Surgical Company

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of May 09, 2025, STAAR Surgical Company has a weighted four-quarter relative price strength of -15.90%, which translates to a Momentum Score of 16 and is considered to be Very Weak.

Want to learn more about how STAAR Surgical Company is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

STAAR Surgical Company Stock Price: Bottom Line

As of May 12, 2025, STAAR Surgical Company’s stock price is $20.430, which is up 5.2% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like STAAR Surgical Company stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.